메인콘텐츠 바로가기 메뉴영역 바로가기
하이로닉 로고

하이로닉 인터내셔널 웹사이트로 이동합니다.
인터내셔널 웹사이트에는 수출용 제품으로 대한민국에서 허가하지 않은 장비 및 서비스 내용을 포함하고 있습니다. 해당 내용은 대한민국의 의료기기 광고 심의, 규제를 받지 않습니다.

인터내셔널 웹사이트 →

It goes to the HIRONIC INTL. website.
The Intrrnation Web Site contains equipment and services that are not authorized by the Republic of Korea These contents are not subject to review and regulation of medical devices in Korea.

International Website →
닫기
하이로닉 로고

하이로닉 US 웹사이트로 이동합니다.
US 웹사이트의 내용은 "FDA"로 부터 허가승인된 품목의 제품 정보에 관한 것으로, 대한민국의 소비자 보호를 위한 국내법 의료기기의 광고 심의, 규제를 받지 않습니다.

US 웹사이트 →

It goes to the HIRONIC US website.
The contents of the US web page are about product information of items approved for "FDA". They are not subject to advertising deliberation and regulation of domestic law medical devices for consumer protection in Korea.

US Website →
닫기
하이로닉 로고

하이로닉 EU 웹사이트로 이동합니다.
EU 웹사이트의 내용은 "CE MDD 또는 CE MDR"로 부터 허가승인된 품목의 제품 정보에 관한 것으로, 대한민국의 소비자 보호를 위한 국내법 의료기기의 광고 심의, 규제를 받지 않습니다.

EU 웹사이트 →

It goes to the HIRONIC EU website.
The contents of the EU(European) web page are about product information of items approved for "CEMDD or CEMDR" in EU countries. They are not subject to advertising deliberation and regulation of domestic law medical devices for consumer protection in Korea.

EU Website →
닫기
NEWS
  • 제목HIRONIC GLOBAL LAUNCHING SYMPOSIUM 2026
  • 조회수39
  • 작성일26-11-02 14:00

 

9bd3615e3fd07149077346deaf067ea9_1793595


Hironic Hosts First Online Global Launch Symposium for Overseas Distributors, Unveiling 'MIGLOU' and 'SYNERJET PRO'


SEOUL — Hironic, a medical aesthetic device specialist, announced on the 21st that it successfully held its first online global launch symposium for overseas distribution partners on the 14th and 15th. During the event, the company introduced its latest innovations: MIGLOU and SYNERJET PRO.

 

Organized in celebration of Hironic's 20th anniversary, the symposium was hosted by the company's global clinical training platform, "H-Academy." The sessions were divided across three major regions—Europe, the Middle East, and Africa (EMEA); Asia-Pacific (APAC); and the Americas—and broadcast live from Seoul to accommodate local time zones. Around 120 representatives from distribution partners across 31 countries attended the event.

 

SYNERJET PRO is a needle-free injector combining three distinct technologies: microjet delivery, low-frequency stimulation via electroporation tips, and plasma. In April and August of this year, the device received 510(k) clearances from the U.S. Food and Drug Administration (FDA) for its electrosurgical plasma function and transdermal electrical stimulation for aesthetic purposes, respectively.

 

MIGLOU utilizes 2.45 GHz microwave energy alongside Hironic's proprietary Focused Intensive Microwave (FIM) technology. The device also features contact cooling capabilities and two smart safety sensors to ensure safe and precise delivery.

 

Hironic plans to leverage the symposium to deepen collaboration with its global distribution network and expand regional supply in line with local regulatory approval timelines worldwide.

 

"Through this symposium, we shared real-world clinical treatment insights for both MIGLOU and SYNERJET PRO with our partners around the globe," said Jin-woo Lee, CEO of Hironic. "We will translate the strong interest from partners across these three regions into new business opportunities and accelerate our global market expansion."